Back to results
US 2016/0101118 A1Published application
Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
AssigneeImprimis Pharmaceuticals, Inc.
InventorsErnesto Fernandez, William F. Wiley
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), at least one pharmaceutically acceptable excipient and a pharmaceutically acceptable carrier. Methods for fabricating the compositions and using them for intraocular injections are also described.
Claims28
A pharmaceutical composition, comprising:
- (a) a therapeutic component consisting essentially of:
- (a1) a therapeutically effective quantity of an anti-bacterial agent independently selected from the group consisting of quinolone, a fluorinated quinolone and pharmaceutically acceptable salts, hydrates, solvates or N-oxides thereof;
- and
- (a2) a therapeutically effective quantity of a corticosteroid independently selected from the group consisting of prednisone, prednisolone, methylprednisone, corticol, cortisone, fluorocortisone, deoxycorticosterone acetate, aldosterone, budesonide, derivatives or analogs thereof and pharmaceutically acceptable salts, hydrates, solvates, ethers, esters, acetals and ketals thereof;
- (b) at least one pharmaceutically acceptable solubilizing and suspending agent selected from the group consisting of non-ionic polyoxyethlene-polyoxypropylene block copolymers;
- and
- (c) optionally, a pharmaceutically acceptable carrier therefor,
- wherein the composition is free of preservatives.
5 more elements
Dependencies are inferred from the claim text.